NCT01924468View on ClinicalTrials.gov

Brain Networks and Addiction Susceptibility

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 14, 2013

Primary Completion Date

September 5, 2018

Study Completion Date

May 14, 2019

Conditions
Nicotine Dependence
Interventions
DRUG

Oral methylphenidate and Oral haloperidol

Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01924468 - Brain Networks and Addiction Susceptibility | Biotech Hunter | Biotech Hunter